U.S. market Closed. Opens in 1 day 6 hours 27 minutes

CUE | Cue Biopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
Revenue5.49M1.25M14.94M3.15M3.46M1.14MN/AN/AN/A
Cost of Revenue38.10M1.81M-1.78M33.55M27.49M28.54M419.57K202.09K44.81K
Gross Profit-32.61M-560.83K16.72M-30.39M-24.03M-27.40M-419.57K-202.09K-44.81K
Operating Expenses19.54M54.75M58.65M48.20M40.23M39.84M23.23M7.66M1.93M
Selling, General & Admin16.68M16.17M17.31M14.65M12.74M11.30M4.33M1.97M425.08K
Research & Development40.80M38.58M41.35M33.55M27.49M28.54M18.90M5.69M1.50M
Other Operating Expenses-37.94MN/AN/AN/A64.00K165.34KN/AN/AN/A
Operating Income-52.15M-53.22M-43.71M-45.04M-36.77M-38.70M-23.23M-7.66M-1.93M
Other Expenses / Income1.42M215.00K45.90K463.91K482.79K541.35K35.0052.00N/A
Before Tax Income-50.73M-53.01M-43.67M-44.58M-36.29M-38.16M-23.23M-7.66M-1.93M
Income Tax ExpensesN/A-214.43K495.00K206.25K412.00K825.00KN/AN/AN/A
Net Income-50.73M-52.80M-44.16M-44.78M-36.70M-38.98M-23.23M-7.66M-1.93M
Interest Expenses1.25M713.82KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding45.75M35.65M31.29M28.69M22.04M20.13M20.64M20.64M20.64M
Diluted Shares Outstanding45.75M35.65M31.29M28.69M22.04M20.13M20.64M20.64M20.64M
EBITDA-46.05M-50.49M-45.44M-43.99M-35.96M-37.94M-22.81M-7.46M-1.88M
EBITDA Margin-838.83%-4,054.72%-304.15%-1,394.44%-1,039.86%-3,320.19%0.00%0.00%0.00%
EBIT-49.49M-52.30M-43.67M-44.58M-36.29M-38.16M-23.23M-7.66M-1.93M
EBIT Margin-901.42%-4,199.76%-292.25%-1,413.26%-1,049.33%-3,339.33%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙